Overview
- Deputy Chief Minister Rajendra Shukla said 20 children from Madhya Pradesh have died, including two in the past 24 hours, after consuming Coldrif linked to acute kidney failure.
- Multiple states have prohibited the implicated Coldrif batch SR‑13 and ordered seizures, with recent actions by Punjab, Himachal Pradesh, Uttar Pradesh, Karnataka and Puducherry alongside earlier bans in Tamil Nadu, Madhya Pradesh and Kerala.
- Madhya Pradesh also flagged two additional syrups, ReLife and Respifresh TR, for diethylene glycol above limits and halted their sale and ordered seizures, as Gujarat moved to ban the pair.
- Tamil Nadu’s Drugs Control Department issued a show‑cause notice to manufacturer Sresan Pharmaceuticals, cited over 350 critical and major manufacturing lapses, halted production and confirmed DEG levels near 48.6% in sampled Coldrif.
- Investigations include an SIT in MP, suspensions and a doctor’s arrest, NHRC notices to states and central regulators, and a DGHS advisory urging judicious pediatric prescribing and avoiding cough medicines in children under two.